TickerFacts.

Gain Therapeutics, Inc. (GANX): Net Income

Annual figures by period end, from SEC filings.

-$20.16M
Year ended 2025-12-31
-$20.11M
Trailing 12 months to 2026-06-30
2020-12-31: -$3.58M2021-12-31: -$13.89M2022-12-31: -$17.59M2023-12-31: -$22.27M2024-12-31: -$20.41M2025-12-31: -$20.16M-$20.16M
2020-12-31 Net Income (USD) 2025-12-31
Period endedNet IncomeChange YoYSource filing
2025-12-31-$20.16Mn/m2026-03-26, From 2025-01-01
2024-12-31-$20.41Mn/m2026-03-26, From 2024-01-01
2023-12-31-$22.27Mn/m2025-03-27, From 2023-01-01
2022-12-31-$17.59Mn/m2024-03-26, From 2022-01-01
2021-12-31-$13.89Mn/m2023-03-23, From 2021-01-01
2020-12-31-$3.58Mn/a2022-03-25, From 2020-01-01

Net Income at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedNet IncomeChange YoY
Gain Therapeutics, Inc. (GANX)2025-12-31-$20.16Mn/m
CervoMed Inc. (CRVO)2025-12-31-$26.97Mn/m
Faeth Therapeutics, Inc. (FTH)2025-12-31-$21.09Mn/m
Moleculin Biotech, Inc. (MBRX)2025-12-31-$33.56Mn/m
BriaCell Therapeutics Corp. (BCTX)2025-07-31-$26.31Mn/m
Immunic, Inc. (IMUX)2025-12-31-$97.17Mn/m
Rein Therapeutics, Inc. (RNTX)2025-12-31-$49.87Mn/m
Phio Pharmaceuticals Corp. (PHIO)2025-12-31-$8.70Mn/m
Kiora Pharmaceuticals Inc (KPRX)2025-12-31-$10.84Mn/m

Compare GANX, CRVO, FTH, MBRX side by side · Screen every company in Pharmaceutical Preparations ↗